Arcturus Therapeutics to Participate in Piper Sandler 33rd Annual Healthcare Conference

Arcturus Therapeutics Holdings Inc. (the Company, Arcturus, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that members of the Companys management team will be participating in the Piper Sandlers 33rd Annual Virtual Healthcare Conference and investor meetings between November 30, 2021 and December 02, 2021.